Astrana Health Inc
ASTHHealthcare·Medical Care Facilities·USA·Small·NASD·Nov 13 • 7:22 AM ET
31.68-0.09 (-0.28%)
2026-11-13 13:31 CET
Market cap
$1.57B
Revenue, TTM
3,911.76 USD m
Net income, TTM
53.13 USD m
Free cash flow, TTM
99.42 USD m
EPS diluted, TTM
1.07
29.57
Price
ASTH against its 20, 50 and 200-day averagesPatternshover a marker to name it
38.6% under the 52-week high of 51.60 on 2 Jul 2026. 52-week low 18.08 on 12 Feb 2026. Last 15 sessions, 31.2% high to low
Volume 0.00× normal · the line is the 50-bar volume average
Setup. RS line 29
CANSLIM 4 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
VCP 4 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 52-Week High/Low: 0-10% below High
Minervini 1 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 3 of 4 — fails: Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25
Value 1 of 4 — fails: P/E: Under 15; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 1 of 4 — fails: Dividend Growth: Growing 2+ Years; P/E: Under 25 — not on the tape: Dividend Yield: Over 2%
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 2 of 4 — fails: Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K
Profile
ASTH52-week range, 41% of the way up
18.0851.60
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam in 1985 and is headquartered in Alhambra, CA.
| Index | RUT |
|---|---|
| Employees | 3000 |
| IPO | Oct 23, 2006 |
| Beta | 1.25 |
| ATR, 14d | 1.94 |
| Rel volume | 0.00 |
| Short float | 7.89% |
| Insider own | 23.50% |
| Inst own | 67.38% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $1.57B |
| Enterprise Value | 1.93B |
| Income | 53.13M |
| Sales | 3.91B |
| Book / share | 17.37 |
| Cash / share | 8.03 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | 0.00% |
| Employees | 3000 |
| IPO | Oct 23, 2006 |
Ratios
| Price / earnings | 29.57 |
|---|---|
| Forward price / earnings | 16.96 |
| Price / earnings / growth | 0.22 |
| Price / sales | 0.40 |
| Price / book | 1.82 |
| Price / cash | 3.94 |
| Price / free cash flow | 15.81 |
| Value / cash profit | 10.45 |
| Value / sales | 0.49 |
| Quick Ratio | 1.25 |
| Current Ratio | 1.25 |
| Debt / equity | 1.14 |
| Long-term debt / equity | 1.06 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | 1.07 |
|---|---|
| Earnings next year | 1.87 |
| Earnings next quarter | 0.22 |
| Earnings this year | 169.82% |
| Earnings next year | 50.51% |
| Earnings growth, 5 years | 76.25% |
| Past earnings growth | -22.81% -14.74% |
| Past sales growth | 40.62% 35.87% |
| Earnings vs last year | 463.11% |
| Sales vs last year | 35.05% |
| Earnings vs last quarter | 3360.00% |
| Sales vs last quarter | 7.07% |
| Earnings | Nov 05 AMC |
| Surprise | -43.16% 0.35% |
Ownership
| Insiders own | 23.50% |
|---|---|
| Insider trades | 0.00% |
| Institutions own | 67.38% |
| Institution trades | 4.78% |
| Return on assets | 2.32% |
| Return on equity | 6.51% |
| Return on capital | 3.01% |
| Gross Margin | 9.34% |
| Operating margin | 3.10% |
| Profit Margin | 1.36% |
| 20-day average | -12.17% |
| 50-day average | -12.98% |
| 200-day average | -7.66% |
Technical
| Shares out | 49.32M |
|---|---|
| Shares floating | 37.95M |
| Short / float | 7.89% |
| Short ratio | 7.96 |
| Short interest | 2.99M |
| 52-week high | 51.60 -38.6% |
| 52-week low | 18.08 +75.2% |
| Volatility | 8.03% 5.29% |
| Average range | 1.94 |
| Strength index | 33.80 |
| Market sensitivity | 1.25 |
| Relative volume | 0.00 |
| Avg Volume | 376.36K |
| Volume | 62 |
Performance
| Perf Week | -8.17% |
|---|---|
| Perf Month | -16.70% |
| Perf Quarter | -20.30% |
| Perf Half Y | -17.20% |
| Perf YTD | 27.69% |
| Perf Year | 44.59% |
| Perf 3Y | 1.05% |
| Perf 5Y | -71.18% |
| Perf 10Y | 604.00% |
| Recommendation | 1.36 |
| Target Price | 51.89 |
| Prev Close | 31.77 |
| Price | 31.68 |
| Change % | -0.28% |
Analyst ratings
latest 10 of 18| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Sep 15, 2026 | Initiated | Oppenheimer | Outperform | $53 | +67.3% |
| May 26, 2026 | Upgrade | Barclays | Equal Weight → Overweight | $50 | +57.8% |
| Dec 12, 2025 | Initiated | Needham | Buy | $28 | -11.6% |
| Apr 01, 2025 | Initiated | Barclays | Equal Weight | $36 | +13.6% |
| Oct 14, 2024 | Initiated | TD Cowen | Buy | $66 | +108.3% |
| Oct 11, 2024 | Initiated | KeyBanc Capital Markets | Sector Weight | ||
| Jul 11, 2024 | Upgrade | Truist | Hold → Buy | $44 → $50 | +57.8% |
| May 30, 2024 | Initiated | Robert W. Baird | Outperform | $54 | +70.5% |
| Feb 26, 2024 | Initiated | Jefferies | Buy | $50 | +57.8% |
| Feb 22, 2024 | Upgrade | BofA Securities | Neutral → Buy | $44 → $55 | +73.6% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| AGL | Agilon Health Inc | 1.85B |
| PRVA | Privia Health Group Inc | 3.02B |
| ALHC | Alignment Healthcare Inc | 1.56B |
| INNV | InnovAge Holding Corp | 1.28B |
| PIII | P3 Health Partners Inc | 18.30M |
| EVH | Evolent Health Inc | 538.38M |
| CLOV | Clover Health Investments Corp | 2.58B |
| NUTX | Nutex Health Inc | 1.18B |
| UNH | Unitedhealth Group Inc | 362.39B |
| HUM | Humana Inc | 53.27B |
Insider trading
4 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Schmidt David | Director | Aug 14 '26 | Option Exercise | 5.00 | 20,000 | 100,000 | 56,019 | Aug 18 04:15 PM |
| Sim Brandon | CEO and President | Feb 02 '26 | Option Exercise | 23.24 | 21,334 | 495,802 | 1,045,329 | Feb 03 09:37 PM |
| Schmidt David | Director | Jan 13 '26 | Option Exercise | 5.79 | 20,000 | 115,800 | 35,763 | Jan 15 04:15 PM |
| Lam Thomas S. | Director | Dec 08 '25 | Option Exercise | 17.78 | 29,502 | 524,546 | 459,122 | Dec 10 04:15 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IJR | iShares Core S&P Small-Cap ETF | AUM: 107.13B |
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 80.23B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.68B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| SPSM | State Street SPDR Portfolio S&P 600TM Small Cap ETF | AUM: 16.19B |
| DFAS | U.S. Small Cap Portfolio-ETF Class Shares | AUM: 15.64B |
| IJS | iShares S&P Small-Cap 600 Value ETF | AUM: 7.79B |
News
latest 14 of 200- Foothill Regional Medical Center Recognized Among Healthgrades' 2027 America's 100 Best Hospitals for Orthopedic Surgery and Joint Replacement (PR Newswire)
- Astrana Health Misses Consensus As Record EBITDA Meets Unchanged Guidance And Worsening Medicaid Costs (Earnings Whispers) -11.56%
- Astrana Health, Inc. Reports Third Quarter 2026 Results (PR Newswire)
- Astrana Health's Q3 Test: Can Cost Trend And Medicaid Attrition Spare The EBITDA Raise? (Earnings Whispers)
- Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call (PR Newswire)
- Astrana Health Inc (ASTH) (Q2 2026) Earnings Call Highlights: Record EPS and Raised Guidance ... (GuruFocus.com)
- Astrana Health, Inc. Reports Second Quarter 2026 Results (PR Newswire)
- Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call (PR Newswire)
- Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth (PR Newswire)
- Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year (PR Newswire)
- Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth (PR Newswire)
- Astrana Health, Inc. Announces Appointment of Interim National Medical Director (PR Newswire)
- Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care (PR Newswire)
- Astrana Health, Inc. Reports First Quarter 2026 Results (PR Newswire) +8.92%
Quarterly earnings
2026Q3 EPS 0.260 missed 0.457, from 0.010 a year earlier. Sales 1,024 beat 1,020, from 956.05 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-05 16:30 | 0.260 | 0.457 | 0.260 | 1,024 | 1,020 | EPS -43.2% · sales +0.4% | vs 2025Q3, year-ago quarter · EPS +2500.0% · sales +7.1% | 11 EPS · 10 sales | Open -7.25% vs SPY +0.25%. Close -11.56% vs SPY +0.31% |
| 2026Q2ended 2026-06-30 | 2026-08-06 16:30 | 0.400 | 0.336 | 0.397 | 972.5 | 982.23 | EPS +19.1% · sales -1.0% | vs 2025Q2, year-ago quarter · EPS +110.5% · sales +48.5% | 10 EPS · 9 sales | Open +1.20% vs SPY +0.32%. Close +4.78% vs SPY +0.61% |
| 2026Q1ended 2026-03-31 | 2026-05-07 16:30 | 0.290 | 0.299 | 0.294 | 965.1 | 949.21 | EPS -2.9% · sales +1.7% | vs 2025Q1, year-ago quarter · EPS +107.1% · sales +55.6% | 11 EPS · 10 sales | Open +2.30% vs SPY +0.46%. Close +8.92% vs SPY +0.83% |
| 2025Q4ended 2025-12-31 | 2026-03-02 08:30 | 0.120 | 0.106 | 0.121 | 950.53 | 930.43 | EPS +12.9% · sales +2.2% | vs 2024Q4, year-ago quarter · EPS -180.0% · sales +42.9% | 10 EPS · 9 sales | Open +18.25% vs SPY -1.06%. Close +29.46% vs SPY +0.06% |
| 2025Q3ended 2025-09-30 | 2025-11-06 16:30 | 0.010 | 0.466 | 0.008 | 956.05 | 952.83 | EPS -97.9% · sales +0.3% | vs 2024Q3, year-ago quarter · EPS -97.0% · sales +99.7% | 6 EPS · 8 sales | Open -7.07% vs SPY -0.36%. Close -23.46% vs SPY +0.10% |
| 2025Q2ended 2025-06-30 | 2025-08-07 16:30 | 0.190 | 0.349 | 0.191 | 654.81 | 638.33 | EPS -45.5% · sales +2.6% | vs 2024Q2, year-ago quarter · EPS -52.5% · sales +34.7% | 9 | Open +11.84% vs SPY +0.29%. Close +30.85% vs SPY +0.78% |
| 2025Q1ended 2025-03-31 | 2025-05-08 16:30 | 0.140 | 0.207 | 0.137 | 620.39 | 630.68 | EPS -32.4% · sales -1.6% | vs 2024Q1, year-ago quarter · EPS -54.8% · sales +53.4% | 10 | Open -3.99% vs SPY +0.25%. Close -11.14% vs SPY -0.13% |
| 2024Q4ended 2024-12-31 | 2025-02-27 16:30 | -0.150 | 0.099 | -0.145 | 665.21 | 617.24 | EPS -251.5% · sales +7.8% | vs 2023Q4, year-ago quarter · EPS -157.7% · sales +88.4% | 10 EPS · 12 sales | Open -10.01% vs SPY +0.09%. Close -26.82% vs SPY +1.56% |
| 2024Q3ended 2024-09-30 | 2024-11-07 16:30 | 0.330 | 0.309 | 0.334 | 478.71 | 462.41 | EPS +6.7% · sales +3.5% | vs 2023Q3, year-ago quarter · EPS -29.8% · sales +37.5% | 9 EPS · 10 sales | Open -2.83% vs SPY +0.09%. Close -20.51% vs SPY +0.43% |
| 2024Q2ended 2024-06-30 | 2024-08-07 16:30 | 0.400 | 0.393 | 0.400 | 486.27 | 447.47 | EPS +1.9% · sales +8.7% | vs 2023Q2, year-ago quarter · EPS +42.9% · sales +39.6% | 8 | Open +11.84% vs SPY +1.01%. Close +1.06% vs SPY +2.31% |
| 2024Q1ended 2024-03-31 | 2024-05-07 16:30 | 0.310 | 0.303 | 0.311 | 404.36 | 413.84 | EPS +2.5% · sales -2.3% | vs 2023Q1, year-ago quarter · EPS 0.0% · sales +19.9% | 6 EPS · 7 sales | Open -2.45% vs SPY -0.36%. Close +0.42% vs SPY +0.01% |
| 2023Q4ended 2023-12-31 | 2024-02-27 16:30 | 0.260 | 0.148 | 0.260 | 353.04 | 341.17 | EPS +76.0% · sales +3.5% | vs 2022Q4, year-ago quarter · EPS -533.3% · sales +20.0% | 6 EPS · 7 sales | Open +1.86% vs SPY -0.32%. Close +0.53% vs SPY -0.13% |
| 2023Q3ended 2023-09-30 | 2023-11-07 16:30 | 0.470 | 0.330 | 0.470 | 348.17 | 349.49 | EPS +42.4% · sales -0.4% | vs 2022Q3, year-ago quarter · EPS -16.1% · sales +9.8% | 4 | - |
| 2023Q2ended 2023-06-30 | 2023-08-07 16:30 | 0.280 | 0.249 | 0.282 | 348.21 | 341.97 | EPS +12.4% · sales +1.8% | vs 2022Q2, year-ago quarter · EPS +12.0% · sales +29.1% | 3 | - |
| 2023Q1ended 2023-03-31 | 2023-05-08 16:30 | 0.310 | 0.307 | 0.280 | 337.24 | 318.07 | EPS +1.1% · sales +6.0% | vs 2022Q1, year-ago quarter · EPS 0.0% · sales +28.1% | 3 | - |
| 2022Q4ended 2022-12-31 | 2023-02-23 16:30 | -0.060 | -0.070 | -0.056 | 294.21 | 247.35 | EPS -14.3% · sales +18.9% | vs 2021Q4, year-ago quarter · EPS -120.0% · sales +50.8% | 2 | - |
Annual earnings
2025FY EPS 0.460 missed 0.493, from 0.900 a year earlier. Sales 3,182 beat 3,161, from 2,035 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 3.760 | - | - | 5,553 | 8.43 |
| 2029FYestimate | - | 3.230 | - | - | 5,121 | 9.81 |
| 2028FYestimate | - | 2.519 | - | - | 4,814 | 12.58 |
| 2027FYestimate | - | 1.868 | - | - | 4,367 | 16.96 |
| 2026FYestimate | - | 1.241 | - | - | 3,973 | 25.52 |
| 2025FY | 0.460 | 0.493 | 0.460 | 3,182 | 3,161 | 53.94 |
| 2024FY | 0.900 | 1.136 | 0.899 | 2,035 | 1,987 | 35.03 |
| 2023FY | 1.290 | 1.180 | 1.293 | 1,387 | 1,375 | 29.69 |
| 2022FY | 1.080 | 1.045 | 0.991 | 1,144 | 1,097 | 27.40 |
| 2021FY | 1.630 | 1.590 | 1.518 | 773.92 | 755.06 | 45.08 |
| 2020FY | 1.010 | 0.920 | 1.011 | 687.18 | 674.9 | 18.09 |
| 2019FY | 0.390 | 0.400 | 0.388 | 560.62 | 535.54 | 47.21 |
| 2018FY | 0.290 | 0.490 | 0.286 | 519.91 | 555.16 | 68.45 |
| 2017FY | 0.900 | - | 0.900 | 357.75 | - | 26.67 |
| 2014FY | -0.370 | - | -0.370 | 32.99 | - | - |
Quarterly results
2026Q3 revenue 1,024, from 956.05 a year earlier. Operating margin 3.9%, from 2.0% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E 1.24 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-10 | 1.24 | -1.4% |
| 2026Q4 | E | per share | 2026-11-10 | 0.22 | -2.4% |
| 2026FY | R | per share | 2026-11-10 | 1.24 | -1.4% |
| 2026Q4 | R | per share | 2026-11-10 | 0.22 | -2.4% |
| 2026FY | S | USD millions | 2026-11-10 | 3,973 | 0.0% |
| 2026Q4 | S | USD millions | 2026-11-10 | 1,015 | -0.1% |
| 2026Q3 | E | per share | 2026-11-01 | 0.46 | 0.0% |
| 2026Q3 | R | per share | 2026-11-01 | 0.46 | 0.0% |
| 2026Q3 | S | USD millions | 2026-10-30 | 1,020 | +0.0% |
| 2026Q2 | E | per share | 2026-08-05 | 0.34 | -0.1% |
| 2026Q2 | R | per share | 2026-08-05 | 0.34 | -0.1% |
| 2026Q2 | S | - | 2026-08-05 | 985.62 | 0.0% |
| 2026Q1 | S | - | 2026-05-01 | 949.21 | +0.0% |
| 2026Q1 | E | per share | 2026-04-15 | 0.30 | +3.1% |
| 2026Q1 | R | per share | 2026-04-15 | 0.30 | +3.1% |
| 2025FY | E | per share | 2026-03-02 | 0.51 | +3.3% |
| 2025Q4 | E | per share | 2026-03-02 | 0.11 | +5.8% |
| 2025FY | R | per share | 2026-03-02 | 0.51 | +3.3% |
| 2025Q4 | R | per share | 2026-03-02 | 0.11 | +5.8% |
| 2025Q4 | S | - | 2026-02-23 | 930.43 | 0.0% |
| 2025FY | S | USD millions | 2026-01-30 | 3,161 | 0.0% |
| 2025Q3 | E | per share | 2025-10-27 | 0.47 | 0.0% |
| 2025Q3 | R | per share | 2025-10-27 | 0.47 | 0.0% |
| 2025Q3 | S | - | 2025-10-27 | 952.83 | 0.0% |
| 2025Q2 | E | per share | 2025-08-03 | 0.35 | 0.0% |
| 2025Q2 | R | per share | 2025-08-03 | 0.35 | 0.0% |
| 2025Q2 | S | - | 2025-08-03 | 638.33 | 0.0% |
| 2025Q1 | E | per share | 2025-04-22 | 0.21 | -5.0% |
| 2025Q1 | R | per share | 2025-04-22 | 0.21 | -5.0% |
| 2025Q1 | S | - | 2025-04-22 | 630.68 | 0.0% |
| 2024FY | S | USD millions | 2025-02-18 | 1,987 | +0.8% |
| 2024Q4 | S | - | 2025-02-18 | 617.24 | +2.4% |
| 2024FY | E | per share | 2025-02-03 | 1.14 | +0.0% |
| 2024Q4 | E | per share | 2025-02-03 | 0.10 | -0.3% |
| 2024FY | R | per share | 2025-02-03 | 1.14 | +0.0% |
| 2024Q4 | R | per share | 2025-02-03 | 0.10 | -0.3% |
| 2024Q3 | E | per share | 2024-10-28 | 0.31 | 0.0% |
| 2024Q3 | R | per share | 2024-10-28 | 0.31 | 0.0% |
| 2024Q3 | S | - | 2024-10-28 | 462.41 | +0.0% |
| 2024Q2 | R | per share | 2024-07-25 | 0.38 | -2.5% |
| 2024Q2 | S | - | 2024-07-25 | 440.68 | 0.0% |
| 2024Q2 | E | per share | 2024-07-24 | 0.39 | +0.7% |
| 2024Q1 | E | per share | 2024-04-30 | 0.30 | -1.1% |
| 2024Q1 | S | - | 2024-04-30 | 413.84 | +0.3% |
| 2024Q1 | R | per share | 2024-02-28 | 0.29 | -43.1% |
| 2023FY | S | USD millions | 2024-02-23 | 1,375 | +0.0% |
| 2023FY | E | per share | 2024-02-22 | 1.18 | -0.4% |
| 2023FY | R | per share | 2024-02-22 | 1.25 | -2.3% |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | 0.9 | 0.286 | 0.388 | 1.011 | 1.518 | 0.991 | 1.293 | 0.899 | 0.456 | 1.0714 | - |
| Sales USD millions | 358 | 520 | 561 | 687 | 774 | 1,144 | 1,387 | 2,035 | 3,182 | 3,912 | - |
| Shares million shares | 32 | 35 | 36 | 42 | 45 | 47 | 47 | 48 | 49 | - | 49 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | 0.334 | -0.145 | 0.137 | 0.191 | 0.008 | 0.121 | 0.294 | 0.397 | 0.26 |
| Sales USD millions | 479 | 665 | 620 | 655 | 956 | 951 | 965 | 973 | 1,024 |
| Shares million shares | 48 | 48 | 49 | 49 | 49 | 49 | 49 | 49 | 49 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,911.76 | 3,181.77+56.4% | 2,034.54+46.7% | 1,386.66+21.2% | 1,144.16+47.8% | 773.91+12.6% | 687.18+22.6% | 560.62+7.8% | 519.91 |
| Cost of Goods Sold Incl. D&A | 3,546.46 | 2,885.99+61.1% | 1,791.08+50.6% | 1,189.45+23.6% | 962.23+56.8% | 613.66+10.1% | 557.56+14.7% | 486.09+27.8% | 380.44 |
| Gross Profit | 365.31 | 295.78+21.5% | 243.46+23.5% | 197.21+8.4% | 181.94+13.5% | 160.26+23.6% | 129.62+73.9% | 74.53-46.6% | 139.47 |
| Selling, General and Administrative Excl. Other | 244.18 | 217.26+41.0% | 154.11+36.9% | 112.60+45.0% | 77.67+25.1% | 62.08+26.4% | 49.12+22.4% | 40.12-15.1% | 47.24 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 121.12 | 78.53-12.1% | 89.35+5.6% | 84.61-18.9% | 104.27+6.2% | 98.18+22.0% | 80.50+133.9% | 34.41-62.7% | 92.23 |
| Interest Expense | 64.64 | 49.93+50.8% | 33.10+105.6% | 16.10+103.3% | 7.92+46.9% | 5.39-43.3% | 9.50+100.8% | 4.73+744.6% | 0.56 |
| Unusual Expense | -7.71 | 0.07 | -0.74-116.2% | 4.58-78.5% | 21.27+98.0% | 10.74 | -99.84-5117.1% | 1.99-47.6% | 3.80 |
| Net Income Before Taxes | 86.65 | 39.61-51.0% | 80.82-10.0% | 89.84+3.7% | 86.62+11.4% | 77.75-56.4% | 178.43+590.5% | 25.84-68.7% | 82.63 |
| Income Taxes | 28.23 | 15.53-49.7% | 30.89-3.4% | 31.99-21.7% | 40.88+29.0% | 31.69-43.5% | 56.11+586.8% | 8.17-63.5% | 22.36 |
| Consolidated Net Income | 58.41 | 24.08-51.8% | 49.93-13.7% | 57.85+26.5% | 45.74-0.7% | 46.05-62.4% | 122.32+592.2% | 17.67-70.7% | 60.27 |
| Net Income From Continuing Operations | 53.13 | 22.49-47.9% | 43.15-28.9% | 60.72+34.4% | 45.17-34.5% | 68.92+82.0% | 37.87+168.2% | 14.12+30.3% | 10.84 |
| Net Income | 53.13 | 22.49-47.9% | 43.15-28.9% | 60.72+34.4% | 45.17-34.5% | 68.92+82.0% | 37.87+168.2% | 14.12+30.3% | 10.84 |
| EPS (Recurring) per share | 0.96 | 0.46-48.3% | 0.89-34.6% | 1.36+3.0% | 1.32-21.4% | 1.68 | -0.86-300.0% | 0.43+19.4% | 0.36 |
| EPS (Basic, Before Extraordinaries) per share | 1.08 | 0.46-49.5% | 0.91-30.0% | 1.30+30.0% | 1.00-36.3% | 1.57+51.0% | 1.04+153.7% | 0.41+24.2% | 0.33 |
| EPS (Diluted) per share | 1.07 | 0.46-48.9% | 0.90-30.2% | 1.29+30.3% | 0.99-34.9% | 1.52+50.5% | 1.01+159.0% | 0.39+34.5% | 0.29 |
| EBITDA | 184.18 | 124.27+6.0% | 117.28+14.6% | 102.36-16.0% | 121.81+5.3% | 115.70+17.0% | 98.85+87.6% | 52.69-52.8% | 111.53 |
| Non-Operating Income (Expense) | 22.45 | 11.08-53.5% | 23.82-8.1% | 25.91+124.5% | 11.54 | -4.29-156.6% | 7.58 | -1.85 | -5.24 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 38.42 | 30.49+11.8% | 27.28+56.7% | 17.41+36.9% | 12.72+158.5% | 4.92+99.2% | 2.47+461.4% | 0.44-31.3% | 0.64 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | 29.65 | 29.65 | 24.17 | 39.26 | 20.82 | 45.39 | 18.64 | 48.67 | 71.48 |
| Price To Sales Ratio ratio | 0.45 | 0.38 | 0.74 | 1.30 | 1.18 | 4.31 | 1.00 | 1.20 | 1.45 |
| Gross Margin % | 9.34 | 9.30 | 11.97 | 14.22 | 15.90 | 20.71 | 18.86 | 13.29 | 26.83 |
| Operating Margin % | 3.10 | 2.47 | 4.39 | 6.10 | 9.11 | 12.69 | 11.71 | 6.14 | 17.74 |
| Net Margin % | 1.36 | 0.71 | 2.12 | 4.38 | 3.95 | 8.91 | 5.51 | 2.52 | 2.08 |
| Shares Outstanding million shares | 49.32 | 48.89+2.0% | 47.93+2.3% | 46.84+0.6% | 46.58+4.4% | 44.63+5.6% | 42.25+17.7% | 35.91+3.8% | 34.58 |
| Market Capitalization | 1,575.93 | 1,575.93+1.8% | 1,548.75-30.6% | 2,232.26+33.0% | 1,678.45-48.6% | 3,266.51+386.0% | 672.15+4.6% | 642.37-5.1% | 676.59 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,023.62+7.1% | 972.52+48.5% | 965.10+55.6% | 950.53+42.9% | 956.05+99.7% | 654.81+34.7% | 620.39+53.4% | 665.21+88.4% |
| Cost of Goods Sold Incl. D&A | 915.69+4.7% | 884.05+51.4% | 874.84+57.4% | 871.88+40.0% | 874.45+112.0% | 583.74+38.9% | 555.91+65.7% | 622.86+95.3% |
| Gross Profit | 107.93+32.3% | 88.47+24.5% | 90.27+40.0% | 78.64+85.7% | 81.60+23.2% | 71.06+7.6% | 64.48-6.4% | 42.35+24.3% |
| Selling, General and Administrative Excl. Other | 68.05+9.1% | 54.15+6.7% | 61.74+40.6% | 60.25+44.7% | 62.39+65.1% | 50.73+41.1% | 43.90+13.4% | 41.63+9.7% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 39.88+107.6% | 34.32+68.7% | 28.53+38.6% | 18.39+2454.2% | 19.21-32.4% | 20.34-32.4% | 20.58-31.7% | 0.72 |
| Interest Expense | 15.02-15.2% | 16.00+116.8% | 16.10+120.2% | 17.52+117.1% | 17.72+100.0% | 7.38-14.1% | 7.31-3.6% | 8.07+48.9% |
| Unusual Expense | -1.13-239.5% | -4.73 | -1.08-2800.0% | -0.77 | 0.81+44.6% | -0.01-104.8% | 0.04 | -0.32 |
| Net Income Before Taxes | 32.22+468.3% | 27.21+61.8% | 19.71+105.3% | 7.51 | 5.67-78.9% | 16.82-47.3% | 9.60-60.0% | -1.90-306.5% |
| Income Taxes | 11.95+160.3% | 8.76+32.5% | 6.58+94.7% | 0.94-84.0% | 4.59-41.4% | 6.61-34.1% | 3.38-52.7% | 5.88+476.5% |
| Consolidated Net Income | 20.27+1776.9% | 18.45+80.5% | 13.13+111.1% | 6.56 | 1.08-94.3% | 10.22-53.3% | 6.22-63.1% | -7.78 |
| Net Income From Continuing Operations | 12.95+3400.0% | 19.74+109.6% | 14.44+115.8% | 6.00 | 0.37-97.7% | 9.42-50.9% | 6.69-54.9% | -6.95-156.2% |
| Net Income | 12.95+3400.0% | 19.74+109.6% | 14.44+115.8% | 6.00 | 0.37-97.7% | 9.42-50.9% | 6.69-54.9% | -6.95-156.2% |
| EPS (Recurring) per share | 0.24+1100.0% | 0.33+73.7% | 0.28+100.0% | 0.11 | 0.02-94.1% | 0.19-52.5% | 0.14-53.3% | -0.15-162.5% |
| EPS (Basic, Before Extraordinaries) per share | 0.26+2500.0% | 0.40+110.5% | 0.30+114.3% | 0.12 | 0.01-97.1% | 0.19-52.5% | 0.14-54.8% | -0.14-153.8% |
| EPS (Diluted) per share | 0.26+2500.0% | 0.40+110.5% | 0.29+107.1% | 0.12 | 0.01-97.0% | 0.19-52.5% | 0.14-54.8% | -0.14-153.8% |
| EBITDA | 55.50+59.5% | 49.87+83.1% | 44.01+60.4% | 34.80+293.2% | 34.80-2.5% | 27.24-27.4% | 27.43-22.1% | 8.85+759.2% |
| Non-Operating Income (Expense) | 6.24+25.1% | 4.15+7.8% | 6.20 | 5.86+14.0% | 4.99-36.0% | 3.85-63.8% | -3.63-872.3% | 5.14-42.4% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 12.29+102.1% | 9.31+0.6% | 7.82+26.7% | 8.99-25.3% | 6.08+24.8% | 9.25+58.4% | 6.17+35.9% | 12.04+75.8% |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | 29.65 | 75.66 | 53.76 | 130.58 | 54.92 | 34.30 | 34.48 | 24.17 |
| Price To Sales Ratio ratio | 0.45 | 0.60 | 0.34 | 0.39 | 0.48 | 0.51 | 0.67 | 0.74 |
| Gross Margin % | 10.54 | 9.10 | 9.35 | 8.27 | 8.53 | 10.85 | 10.39 | 6.37 |
| Operating Margin % | 3.90 | 3.53 | 2.96 | 1.94 | 2.01 | 3.11 | 3.32 | 0.11 |
| Net Margin % | 1.27 | 2.03 | 1.50 | 0.63 | 0.04 | 1.44 | 1.08 | -1.04 |
| Shares Outstanding million shares | 49.32-0.1% | 49.23+0.2% | 48.95-0.2% | 48.89+2.0% | 49.38+3.3% | 49.14+3.4% | 49.03+3.3% | 47.93+2.3% |
| Market Capitalization | 1,575.93+11.3% | 2,301.17+85.2% | 1,229.82-20.9% | 1,244.36-19.7% | 1,415.44-50.2% | 1,242.23-37.4% | 1,554.21-22.9% | 1,548.75-30.6% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 429.59+47.7% | 290.83-1.8% | 296.31+0.9% | 293.59+2.5% | 286.51+9.7% | 261.17+18.8% | 219.80+103.5% | 108.02-10.7% | 120.92 |
| Short Term Receivables | 407.57+25.5% | 324.80+119.8% | 147.75+23.4% | 119.73+20.6% | 99.31+63.7% | 60.66-38.7% | 98.95+75.3% | 56.46+180.6% | 20.12 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 26.15+14.4% | 22.86+31.0% | 17.45+17.9% | 14.80-20.6% | 18.64+11.3% | 16.75+62.3% | 10.32+23.0% | 8.39+168.1% | 3.13 |
| Total Current Assets | 863.31+35.2% | 638.50+38.4% | 461.51+7.8% | 428.12+5.8% | 404.46+19.5% | 338.58+2.9% | 329.07+90.4% | 172.86+19.9% | 144.16 |
| Net Property, Plant & Equipment | 93.07+98.5% | 46.88+5.2% | 44.57-65.4% | 128.98+87.9% | 68.63+41.6% | 48.46+83.7% | 26.38+107.4% | 12.72-7.9% | 13.81 |
| Total Investments and Advances | 33.10-32.3% | 48.86+50.2% | 32.52-26.8% | 44.40+4.2% | 42.61-47.3% | 80.87+168.9% | 30.07-16.5% | 36.03+59.1% | 22.65 |
| Long-Term Note Receivable | 48.72-5.0% | 51.27+93.7% | 26.47+66.1% | 15.94-3.5% | 16.51+257.4% | 4.62 | 0.00-100.0% | 17.50+16.7% | 15.00 |
| Intangible Assets | 1,136.27+111.4% | 537.43+53.3% | 350.48+1.3% | 345.91+5.1% | 329.22+1.0% | 326.04-4.5% | 341.52+25.2% | 272.68-7.1% | 293.38 |
| Deferred Tax Assets | 30.02+45.3% | 20.66-6.7% | 22.14-6.6% | 23.70+24.1% | 19.09 | - | - | - | - |
| Other Assets | 44.18+38.2% | 31.96+79.3% | 17.82+523.1% | 2.86-51.8% | 5.93-68.6% | 18.91+1025.6% | 1.68+38.8% | 1.21-25.8% | 1.63 |
| Total Assets | 2,248.68+63.5% | 1,375.55+44.0% | 955.50-3.5% | 989.91+11.7% | 886.45+8.4% | 817.49+12.2% | 728.71+42.0% | 513.00+4.6% | 490.64 |
| Short Term Debt Incl. Current Port. of LT Debt | 55.67+264.3% | 15.28-38.3% | 24.75+416.7% | 4.79+22.8% | 3.90-72.5% | 14.17+12.5% | 12.59+8892.9% | 0.14-97.5% | 5.63 |
| Accounts Payable | 44.84+195.6% | 15.17+67.3% | 9.07-13.4% | 10.47+90.0% | 5.51-42.3% | 9.55+38.2% | 6.91+54.2% | 4.48-83.5% | 27.18 |
| Income Tax Payable | - | - | 0.00-100.0% | 4.28 | 0.00-100.0% | 4.22-6.8% | 4.53-61.0% | 11.62+263.1% | 3.20 |
| Other Current Liabilities | 514.76+53.6% | 335.16+81.3% | 184.85+43.2% | 129.07+22.6% | 105.31+21.0% | 87.05+7.0% | 81.39+45.9% | 55.77-24.2% | 73.59 |
| Total Current Liabilities | 615.27+68.3% | 365.61+67.2% | 218.67+47.1% | 148.61+29.5% | 114.72-0.2% | 114.99+9.1% | 105.42+46.4% | 72.02-34.3% | 109.60 |
| Long Term Debt | 1,022.46+123.9% | 456.56+54.1% | 296.26+31.9% | 224.58+13.9% | 197.09-20.0% | 246.39+1.0% | 243.96+1704.4% | 13.52+2080.6% | 0.62 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 35.51+40.9% | 25.21-3.8% | 26.21-30.9% | 37.92-23.0% | 49.23+349.2% | 10.96-40.0% | 18.27-6.9% | 19.62-21.3% | 24.92 |
| Other Liabilities | 17.11+22.2% | 14.00+290.0% | 3.59-82.3% | 20.26+37.1% | 14.78 | 0.00 | 0.00-100.0% | 1.19-93.8% | 19.19 |
| Total Liabilities | 1,690.35+96.2% | 861.38+58.1% | 544.74+26.3% | 431.37+14.8% | 375.81+0.9% | 372.34+1.3% | 367.65+245.7% | 106.34-31.1% | 154.32 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 779.29+9.3% | 712.72+16.0% | 614.22+13.2% | 542.56+21.1% | 448.17+35.5% | 330.82+72.7% | 191.55+6.1% | 180.55+12.9% | 159.95 |
| Total Shareholders Equity | 779.29+9.3% | 712.72+16.0% | 614.22+13.2% | 542.56+21.1% | 448.17+35.5% | 330.82+72.7% | 191.55+6.1% | 180.55+12.9% | 159.95 |
| Accumulated Minority Interest | -220.96 | -198.55 | -203.45-1372.4% | 15.99-74.4% | 62.48-45.3% | 114.32-32.6% | 169.51-25.0% | 226.12+28.2% | 176.37 |
| Total Equity | 558.33+8.6% | 514.17+25.2% | 410.77-26.5% | 558.55+9.4% | 510.64+14.7% | 445.15+23.3% | 361.06-11.2% | 406.66+20.9% | 336.31 |
| Total Liabilities & Stockholders Equity | 2,248.68+63.5% | 1,375.55+44.0% | 955.50-3.5% | 989.91+11.7% | 886.45+8.4% | 817.49+12.2% | 728.71+42.0% | 513.00+4.6% | 490.64 |
| Book Value Per Share per share | 15.94+7.2% | 14.87+13.4% | 13.11+12.5% | 11.65+16.0% | 10.04+28.2% | 7.83+46.9% | 5.33+2.1% | 5.22+5.5% | 4.95 |
| Tangible Book Value Per Share per share | -7.30-299.5% | 3.66-35.0% | 5.63+33.4% | 4.22+58.1% | 2.67+2327.3% | 0.11 | -4.18 | -2.66 | -4.13 |
| Full-Time Employees people | 3,000+57.9% | 1,900+5.6% | 1,800+32.2% | 1,362+20.2% | 1,133+79.8% | 630+13.5% | 555+12.8% | 492-0.2% | 493 |
| Price to Book Ratio ratio | 1.83 | 2.14 | 3.01 | 2.60 | 7.21 | 2.33 | 3.45 | 3.80 | -7.93 |
| Return on Assets % | 1.24 | 3.70 | 6.24 | 4.90 | 8.09 | 4.90 | 2.27 | 2.16 | - |
| Return on Equity % | 3.01 | 6.50 | 10.50 | 9.06 | 17.70 | 14.50 | 7.59 | 6.36 | - |
| Return on Invested Capital % | 1.25 | 3.69 | 6.67 | 5.89 | 10.68 | 6.56 | 3.24 | 5.58 | 16.07 |
| Quick Ratio ratio | 1.40 | 1.75 | 2.11 | 2.88 | 3.53 | 2.94 | 3.12 | 2.40 | 1.32 |
| Current Ratio ratio | 1.40 | 1.75 | 2.11 | 2.88 | 3.53 | 2.94 | 3.12 | 2.40 | 1.32 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 58.41 | 24.08-51.8% | 49.93-13.7% | 57.85+26.5% | 45.74-0.7% | 46.05-62.4% | 122.32+592.2% | 17.67-70.7% | 60.27 |
| Depreciation | 63.05 | 45.75+63.8% | 27.93+57.4% | 17.75+1.2% | 17.54+0.1% | 17.52-4.5% | 18.35-2.1% | 18.75-2.8% | 19.30 |
| Other Funds (Non Cash) | 48.39 | 52.16+23.6% | 42.20+48.3% | 28.46-9.1% | 31.32+5.8% | 29.60 | -98.70-1498.0% | 7.06-60.6% | 17.93 |
| Funds from Operations | 172.26 | 117.69+1.6% | 115.81+26.4% | 91.61+14.1% | 80.32-20.3% | 100.84+185.3% | 35.35-3.6% | 36.68-58.9% | 89.15 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -58.07 | -3.10 | -63.61 | -23.39-1399.4% | 1.80 | -30.50-382.1% | 10.81 | -22.77 | -63.05 |
| Income Taxes Payable | - | - | - | - | 6.92 | -14.01 | -0.30 | -7.09-184.2% | 8.42 |
| Cash from Operating Activities | 114.19 | 114.60+119.5% | 52.20-23.5% | 68.23-16.9% | 82.13+16.8% | 70.33+52.4% | 46.16+231.8% | 13.91-46.7% | 26.10 |
| Capital Expenditures | -14.78 | -10.11 | -8.03 | -28.53 | -22.94 | -19.22 | -1.16 | -1.04 | -1.17 |
| Net Assets From Acquisitions | -6.88 | -548.60 | -146.30 | -6.59 | -21.40 | -4.06 | -11.35 | -49.40 | -16.71 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00-100.0% | 0.15 | 0.00-100.0% | 0.44+780.0% | 0.050.0% | 0.05+66.7% | 0.030.0% | 0.03 |
| Purchase or Sale of Investments | 0.00 | 15.10 | -12.36 | -6.68-123.8% | 28.11-13.2% | 32.37-64.7% | 91.61 | -119.00 | -0.41 |
| Purchase of Investments | 0.00 | 0.00 | -12.48 | -7.18 | -3.96 | -41.62 | -11.76 | -119.00 | -0.41 |
| Sale Or Maturity of Investments | 0.00 | 15.10+12483.3% | 0.12-75.5% | 0.49-98.5% | 32.07-56.7% | 73.99-28.4% | 103.37 | 0.00 | 0.00 |
| Other Uses | 0.00 | -1.71 | -26.00 | -26.47 | 0.00 | 0.00 | -0.14 | -11.43 | -7.50 |
| Other Sources | 5.72 | 6.32+2330.8% | 0.26-90.3% | 2.68-34.2% | 4.07-31.9% | 5.98-63.8% | 16.50 | 0.00 | 0.00 |
| Cash from Investing Activities | -15.93 | -539.00 | -192.28 | -65.60 | -11.72-177.5% | 15.12-84.2% | 95.49 | -180.84 | -25.76 |
| Cash Dividends Paid | -2.68 | -7.88 | -4.04 | -62.07 | -14.03 | -31.09 | -51.32 | -61.72 | -17.76 |
| Change in Capital Stock | -19.32 | -15.43-17244.4% | 0.09 | -8.67 | -0.62-101.4% | 43.46+323.2% | 10.27 | -3.69 | -0.85 |
| Repurchase of Common Pref Stock | -19.32 | -15.43 | -0.94 | -10.19 | -9.25 | -5.74 | -0.54 | -7.57 | -5.05 |
| Sale of Common Pref Stock | 0.00 | 0.00-100.0% | 1.03-32.2% | 1.52-82.4% | 8.63-82.5% | 49.20+355.6% | 10.80+178.4% | 3.88-7.6% | 4.20 |
| Proceedsfrom Stock Options | 0.00 | 0.00-100.0% | 0.27 | 0.00 | 0.00-100.0% | 40.13 | 0.00-100.0% | 0.75+275.0% | 0.20 |
| Issuance or Reduction of Debt, Net | -127.86 | 604.81+319.5% | 144.16+91.6% | 75.24 | -0.83 | -58.69 | -9.61-104.2% | 228.71+2986.5% | 7.41 |
| Change in Long Term Debt | -127.86 | 604.81+319.5% | 144.16+91.6% | 75.24 | -0.83 | -58.69 | -9.61-103.4% | 281.35+3461.4% | 7.90 |
| Issuance of Long Term Debt | 0.00 | 1,100.10+540.0% | 171.88-38.7% | 280.60+7694.4% | 3.60-98.0% | 179.84 | 0.00-100.0% | 283.83+3447.9% | 8.00 |
| Reduction of Long Term Debt | -127.86 | -495.29 | -27.71 | -205.36 | -4.43 | -238.53 | -9.61 | -2.48 | -0.10 |
| Net Financing Active Other Cash Flow | -11.53 | -12.15 | -5.18 | -1.00 | 0.00 | 0.00 | -1.04 | 0.00 | 0.00 |
| Other Financing Activities Uses | -13.83 | -14.45 | -5.18 | -1.00 | 0.00 | 0.00 | -1.04 | 0.00 | 0.00 |
| Cash from Financing Activities | -161.40 | 569.35+321.6% | 135.04+3758.3% | 3.50 | -15.47 | -46.33 | -51.70-131.7% | 163.30 | -11.20 |
| Net Change in Cash | -63.13 | 144.94 | -5.05-182.5% | 6.12-88.9% | 54.93+40.4% | 39.13-56.5% | 89.96 | -3.63 | -10.86 |
| Free Cash Flow | 99.42 | 104.49+136.6% | 44.17+11.3% | 39.70-32.9% | 59.19+15.8% | 51.11+13.6% | 45.00+249.7% | 12.87-48.4% | 24.93 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow ratio | 18.35 | 12.68 | 37.69 | - | 29.88 | 166.62 | - | - | 104.90 |
| Deferred Taxes & Investment Tax Credit | - | -4.29 | -4.25 | -12.44 | -14.28-286.2% | 7.67 | -6.62 | -6.80 | -8.35 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 398.44-14.0% | 402.14+17.5% | 478.38+83.4% | 429.59+47.7% | 463.45+32.3% | 342.12+4.4% | 260.91-22.6% | 290.83-1.8% |
| Short Term Receivables | 554.40+39.6% | 492.51+34.8% | 500.07+52.2% | 407.57+25.5% | 397.02+75.6% | 365.28+62.2% | 328.64+78.4% | 324.80+119.8% |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 27.13+17.1% | 24.51+12.7% | 25.65+8.2% | 26.15+14.4% | 23.16+18.7% | 21.75+34.1% | 23.71+51.2% | 22.86+31.0% |
| Total Current Assets | 979.97+10.9% | 919.16+26.1% | 1,004.10+63.7% | 863.31+35.2% | 883.63+48.3% | 729.15+28.1% | 613.27+14.2% | 638.50+38.4% |
| Net Property, Plant & Equipment | 114.41+27.0% | 101.76+110.1% | 93.48+96.6% | 93.07+98.5% | 90.10+98.9% | 48.43+23.9% | 47.55+0.9% | 46.88+5.2% |
| Total Investments and Advances | 31.98+8.6% | 32.76-36.9% | 32.17-32.3% | 33.10-32.3% | 29.46-38.7% | 51.90+20.1% | 47.55+9.7% | 48.86+50.2% |
| Intangible Assets | 1,118.92-2.6% | 1,130.31+116.3% | 1,131.92+114.3% | 1,136.27+111.4% | 1,148.33+121.3% | 522.65-0.6% | 528.30-0.3% | 537.43+53.3% |
| Deferred Tax Assets | - | - | - | 30.02+45.3% | - | - | - | 20.66-6.7% |
| Other Assets | 48.77+31.1% | 48.82+16.7% | 48.09+3.5% | 44.18+38.2% | 37.20+69.7% | 41.85+60.8% | 46.45+119.0% | 31.96+79.3% |
| Total Assets | 2,343.43+4.7% | 2,282.08+58.2% | 2,358.83+77.2% | 2,248.68+63.5% | 2,237.19+74.0% | 1,442.35+15.2% | 1,331.26+8.6% | 1,375.55+44.0% |
| Short Term Debt Incl. Current Port. of LT Debt | 70.44+28.0% | 62.79+252.4% | 55.42+208.7% | 55.67+264.3% | 55.05+164.7% | 17.82-20.7% | 17.95-32.0% | 15.28-38.3% |
| Accounts Payable | 54.73-6.4% | 108.02+653.8% | 54.33+264.4% | 44.84+195.6% | 58.50+58.5% | 14.33-62.5% | 14.91-82.4% | 15.17+67.3% |
| Income Tax Payable | 2.56-48.0% | 2.08 | 2.51 | - | 4.92 | - | - | - |
| Other Current Liabilities | 658.33+28.7% | 574.75+34.4% | 633.11+92.8% | 514.76+53.6% | 511.47+100.4% | 427.60+71.6% | 328.41+37.7% | 335.16+81.3% |
| Total Current Liabilities | 786.07+24.8% | 747.64+62.6% | 745.37+106.3% | 615.27+68.3% | 629.93+101.3% | 459.75+48.4% | 361.27+1.7% | 365.61+67.2% |
| Long Term Debt | 906.94-12.1% | 916.62+113.3% | 1,009.77+133.0% | 1,022.46+123.9% | 1,032.20+126.8% | 429.77-5.1% | 433.40+6.4% | 456.56+54.1% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 7.63+72.2% | 8.79+239.4% | 7.40+76.2% | 35.51+40.9% | 4.43+54.9% | 2.59-20.3% | 4.20+11.7% | 25.21-3.8% |
| Other Liabilities | 11.29-29.0% | 10.44-15.1% | 18.83+28.2% | 17.11+22.2% | 15.91+113.3% | 12.29+59.2% | 14.69+92.0% | 14.00+290.0% |
| Total Liabilities | 1,711.93+1.8% | 1,683.50+86.1% | 1,781.37+119.0% | 1,690.35+96.2% | 1,682.46+116.2% | 904.40+16.9% | 813.55+5.1% | 861.38+58.1% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 856.62+10.5% | 830.22+8.5% | 800.27+7.4% | 779.29+9.3% | 775.54+10.1% | 765.46+12.8% | 745.37+14.1% | 712.72+16.0% |
| Total Shareholders Equity | 856.62+10.5% | 830.22+8.5% | 800.27+7.4% | 779.29+9.3% | 775.54+10.1% | 765.46+12.8% | 745.37+14.1% | 712.72+16.0% |
| Accumulated Minority Interest | -225.12 | -231.65 | -222.81 | -220.96 | -220.82 | -227.51 | -227.66 | -198.55 |
| Total Equity | 631.50+13.8% | 598.58+11.3% | 577.46+11.5% | 558.33+8.6% | 554.72+9.4% | 537.95+12.4% | 517.71+14.4% | 514.17+25.2% |
| Total Liabilities & Stockholders Equity | 2,343.43+4.7% | 2,282.08+58.2% | 2,358.83+77.2% | 2,248.68+63.5% | 2,237.19+74.0% | 1,442.35+15.2% | 1,331.26+8.6% | 1,375.55+44.0% |
| Book Value Per Share per share | 17.37+10.6% | 16.87+8.3% | 16.35+7.6% | 15.94+7.2% | 15.70+6.4% | 15.58+9.1% | 15.20+10.4% | 14.87+13.4% |
| Tangible Book Value Per Share per share | -5.32 | -6.10-223.5% | -6.78-253.0% | -7.30-299.5% | -7.55-294.1% | 4.94+53.4% | 4.43+70.4% | 3.66-35.0% |
| Full-Time Employees people | - | - | - | 3,000+57.9% | - | - | - | 1,900+5.6% |
| Price to Book Ratio ratio | 1.83 | 2.84 | 1.54 | 1.58 | 1.82 | 1.64 | 2.09 | 2.14 |
| Return on Assets % | 2.32 | 2.18 | 1.64 | 1.24 | 0.54 | 1.87 | 2.74 | 3.70 |
| Return on Equity % | 6.51 | 5.08 | 3.91 | 3.01 | 1.29 | 3.50 | 5.00 | 6.50 |
| Return on Invested Capital % | 0.73 | 1.13 | 0.80 | 0.33 | 0.02 | 0.79 | 0.57 | -0.59 |
| Quick Ratio ratio | 1.25 | 1.23 | 1.35 | 1.40 | 1.40 | 1.59 | 1.70 | 1.75 |
| Current Ratio ratio | 1.25 | 1.23 | 1.35 | 1.40 | 1.40 | 1.59 | 1.70 | 1.75 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | 20.27+1776.9% | 18.45+80.5% | 13.13+111.1% | 6.56 | 1.08-94.3% | 10.22-53.3% | 6.22-63.1% | -7.78 |
| Depreciation | 15.62+0.1% | 15.55+125.4% | 15.48+126.0% | 16.40+101.7% | 15.60+114.9% | 6.90-7.3% | 6.85+34.3% | 8.13+65.9% |
| Other Funds (Non Cash) | 19.11+63.5% | 5.49-65.3% | 11.05-7.4% | 12.74-14.4% | 11.69+93.2% | 15.80+131.0% | 11.93-17.3% | 14.89+28.1% |
| Funds from Operations | 54.04+112.8% | 40.31+28.7% | 41.57+68.7% | 36.34+95.6% | 25.40-20.5% | 31.32-13.3% | 24.64-15.4% | 18.58+134.6% |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -37.77 | -7.57-112.7% | 26.49 | -39.22 | -15.45-861.1% | 59.58 | -8.01 | -29.53-359.5% |
| Cash from Operating Activities | 16.27+63.4% | 32.75-64.0% | 68.06+309.3% | -2.89 | 9.96-70.7% | 90.90+292.0% | 16.63+178.1% | -10.95-156.7% |
| Capital Expenditures | -3.83 | -3.88 | -4.00 | -3.06 | -2.55 | -1.42 | -3.07 | -2.53 |
| Net Assets From Acquisitions | -3.09 | -3.74-12566.7% | 0.00 | -0.05 | -548.55 | 0.03 | -0.03 | -30.78 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 |
| Purchase or Sale of Investments | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00 | 15.10+15000.0% | -0.08 | 0.08 | -3.93 |
| Purchase of Investments | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 0.02 | -0.02 | -3.93 |
| Sale Or Maturity of Investments | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00 | 15.10+12483.3% | -0.10 | 0.10 | 0.00-100.0% |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00-100.0% | -0.66 | -1.05 | 0.00 | 3.91 |
| Other Sources | 1.12-48.9% | 1.39-5.4% | 1.16+93.3% | 2.06 | 2.19 | 1.47+488.0% | 0.60+5900.0% | 0.00-100.0% |
| Cash from Investing Activities | -5.80 | -6.23 | -2.84 | -1.06 | -534.47 | -1.05 | -2.42 | -33.34 |
| Cash Dividends Paid | -0.93 | -0.10 | -0.10 | -1.56 | -0.10 | -0.78 | -5.46 | -1.92 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.47 | -1.46-244.6% | -2.91 | -15.43-5243.3% | 0.00 | 1.01 | -1.01 | 0.30 |
| Repurchase of Common Pref Stock | 0.47 | -1.46-210.6% | -2.91 | -15.43 | 0.00 | 1.32 | -1.32 | -0.22 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | -0.30 | 0.30 | 0.52+92.6% |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00-100.0% | -0.30 | 0.30 | 0.00 |
| Issuance or Reduction of Debt, Net | -11.97-101.8% | -91.97 | -11.97 | -11.97 | 653.37 | -2.98-105.7% | -33.62-131.6% | -12.43-117.0% |
| Change in Long Term Debt | -11.97-101.8% | -91.97 | -11.97 | -11.97 | 653.37 | -2.98-105.7% | -33.62-131.6% | -12.43-117.0% |
| Issuance of Long Term Debt | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00 | 705.34+45405.8% | 0.00-100.0% | 394.76+258.9% | 0.00-100.0% |
| Reduction of Long Term Debt | -11.97 | -91.97 | -11.97 | -11.97 | -51.97 | -2.98 | -428.38 | -12.43 |
| Net Financing Active Other Cash Flow | -2.60 | -10.55 | -0.98 | 2.61 | -4.78 | -5.92 | -4.05 | -1.21 |
| Other Financing Activities Uses | -2.60 | -10.37 | -1.17 | 0.31 | -4.78 | -5.92 | -4.05 | -1.21 |
| Cash from Financing Activities | -15.03-102.3% | -104.07 | -15.96 | -26.34 | 648.49 | -8.67-118.3% | -44.14-141.6% | -15.25-226.9% |
| Net Change in Cash | -4.55-103.7% | -77.55-195.5% | 49.25 | -30.28 | 123.98+446.6% | 81.19 | -29.94-172.5% | -59.54-399.6% |
| Free Cash Flow | 12.44+68.1% | 28.87-67.7% | 64.06+372.4% | -5.95 | 7.40-76.6% | 89.48+339.7% | 13.56+141.7% | -13.48-210.1% |
| Price to Free Cash Flow ratio | 18.35 | 24.97 | 7.89 | 12.72 | 15.81 | 10.90 | 35.46 | 37.66 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Health Care Capitation | 1,856.79 | 2,924.27 | +57.5% | 91.9% |
| Health Care, Other | 86.22 | 86.20 | 0.0% | 2.7% |
| Health Care, Patient Service | 62.33 | 112.64 | +80.7% | 3.5% |
| Management Service | 13.98 | 30.39 | +117.4% | 1.0% |
| Product and Service, Other | 15.22 | 28.28 | +85.8% | 0.9% |
| Total | 2,034.54 | 3,181.77 | +56.4% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United States | 2,034.54 | 3,181.77 | +56.4% | 100.0% |
| Total | 2,034.54 | 3,181.77 | +56.4% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Care Delivery | 136.67 | 250.74 | +83.5% | 7.9% |
| Care Enablement | 155.45 | 246.66 | +58.7% | 7.8% |
| Care Partners | 1,949.03 | 3,022.60 | +55.1% | 95.0% |
| Consolidation, Policy | -206.61 | -338.24 | +63.7% | -10.6% |
| Total | 2,034.54 | 3,181.77 | +56.4% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 7.89% | 3.0M | 38.0M | 390.85K |
| 2026-10-15 | 7.93% | 3.0M | 38.0M | 446.11K |
| 2026-09-30 | 7.87% | 3.1M | 39.3M | 502.01K |
| 2026-09-15 | 8.34% | 3.3M | 39.3M | 555.19K |
| 2026-08-31 | 8.36% | 3.3M | 39.2M | 594.20K |
| 2026-08-14 | 8.12% | 3.2M | 39.2M | 606.41K |
| 2026-07-31 | 7.21% | 2.8M | 39.2M | 603.29K |
| 2026-07-15 | 6.83% | 2.7M | 39.2M | 592.60K |
| 2026-06-30 | 6.81% | 2.7M | 39.2M | 539.39K |
| 2026-06-15 | 5.96% | 2.4M | 39.6M | 463.34K |
| 2026-05-29 | 6.06% | 2.4M | 39.6M | 492.27K |
| 2026-05-15 | 6.86% | 2.7M | 39.6M | 493.07K |
| 2026-04-30 | 7.32% | 2.9M | 39.1M | 503.96K |
| 2026-04-15 | 6.89% | 2.7M | 39.0M | 521.14K |
| 2026-03-31 | 7.42% | 2.9M | 38.6M | 539.69K |
| 2026-03-13 | 6.73% | 2.6M | 38.6M | 570.26K |
| 2026-02-27 | 7.57% | 2.9M | 38.6M | 524.86K |
| 2026-02-13 | 7.35% | 2.8M | 38.6M | 551.02K |
| 2026-01-30 | 6.63% | 2.6M | 38.7M | 569.05K |
| 2026-01-15 | 6.58% | 2.6M | 38.9M | 520.47K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 12.50 | 17.50 | 21.50 | 22.36 | 752.7% | 1.00 | 0.00 | 0.925 | -0.281 | 0.007 |
| call | 15.00 | 15.00 | 19.00 | 0.00 | 630.0% | 0.00 | 0.00 | 0.908 | -0.276 | 0.008 |
| call | 17.50 | 12.50 | 16.50 | 0.00 | 529.2% | 0.00 | 0.00 | 0.888 | -0.267 | 0.009 |
| call | 20.00 | 10.50 | 14.00 | 16.94 | 443.0% | 1.00 | 0.00 | 0.864 | -0.254 | 0.010 |
| call | 22.50 | 7.70 | 11.50 | 0.00 | 366.7% | 0.00 | 0.00 | 0.835 | -0.238 | 0.012 |
| call | 25.00 | 5.40 | 9.00 | 15.77 | 297.4% | 4.00 | 0.00 | 0.796 | -0.217 | 0.013 |
| call | 30.00 | 1.35 | 4.40 | 8.05 | 190.6% | 11.00 | 0.00 | 0.640 | -0.191 | 0.017 |
| call | 35.00 | 0.10 | 3.10 | 1.55 | 233.1% | 206 | 0.00 | 0.456 | -0.276 | 0.018 |
| call | 40.00 | 0.00 | 0.30 | 0.15 | 122.1% | 1,002 | 0.00 | 0.116 | -0.071 | 0.009 |
| call | 45.00 | 0.00 | 4.70 | 0.30 | 164.1% | 4,369 | 1.00 | 0.093 | -0.081 | 0.008 |
| call | 50.00 | 0.00 | 0.85 | 0.21 | 199.1% | 662 | 0.00 | 0.080 | -0.088 | 0.007 |
| call | 55.00 | 0.00 | 3.40 | 0.85 | 229.3% | 158 | 0.00 | 0.072 | -0.093 | 0.006 |
| call | 60.00 | 0.00 | 3.40 | 5.00 | 255.9% | 16.00 | 0.00 | 0.066 | -0.098 | 0.006 |
| call | 65.00 | 0.00 | 3.40 | 0.00 | 279.6% | 0.00 | 0.00 | 0.062 | -0.101 | 0.006 |
| call | 70.00 | 0.00 | 3.40 | 0.00 | 301.1% | 0.00 | 0.00 | 0.058 | -0.105 | 0.005 |
| put | 12.50 | 0.00 | 3.40 | 0.00 | 668.8% | 0.00 | 0.00 | -0.075 | -0.279 | 0.007 |
| put | 15.00 | 0.00 | 3.10 | 0.00 | 558.8% | 0.00 | 0.00 | -0.092 | -0.274 | 0.008 |
| put | 17.50 | 0.00 | 2.80 | 0.30 | 467.8% | 50.00 | 0.00 | -0.112 | -0.265 | 0.009 |
| put | 20.00 | 0.00 | 3.40 | 0.50 | 389.5% | 51.00 | 0.00 | -0.136 | -0.252 | 0.010 |
| put | 22.50 | 0.00 | 3.40 | 0.90 | 319.8% | 32.00 | 0.00 | -0.165 | -0.235 | 0.012 |
| put | 25.00 | 0.00 | 1.65 | 1.25 | 256.0% | 34.00 | 0.00 | -0.204 | -0.214 | 0.013 |
| put | 30.00 | 0.00 | 2.15 | 0.80 | 164.6% | 55.00 | 0.00 | -0.360 | -0.188 | 0.017 |
| put | 35.00 | 3.20 | 3.80 | 2.70 | 90.2% | 254 | 0.00 | -0.544 | -0.272 | 0.018 |
| put | 40.00 | 6.80 | 9.20 | 6.70 | 181.0% | 242 | 0.00 | -0.884 | -0.067 | 0.009 |
| put | 45.00 | 13.00 | 13.60 | 8.80 | 177.2% | 37.00 | 0.00 | -0.907 | -0.076 | 0.008 |
| put | 50.00 | 16.60 | 19.50 | 15.91 | 296.7% | 0.00 | 0.00 | -0.920 | -0.082 | 0.007 |
| put | 55.00 | 21.20 | 25.00 | 20.50 | 370.9% | 1.00 | 0.00 | -0.928 | -0.087 | 0.006 |
| put | 60.00 | 26.20 | 30.00 | 0.00 | 404.4% | 0.00 | 0.00 | -0.934 | -0.091 | 0.006 |
| put | 65.00 | 31.20 | 35.00 | 0.00 | 434.1% | 0.00 | 0.00 | -0.938 | -0.094 | 0.006 |
| put | 70.00 | 36.20 | 40.00 | 0.00 | 460.8% | 0.00 | 0.00 | -0.942 | -0.097 | 0.005 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-06 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-05 | 8-K | Current report | 2026-11-05 | SEC |
| 2026-10-30 | SCHEDULE 13G/A | SEC | ||
| 2026-10-13 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-10 | SEC |
| 2026-10-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-06 | SEC |
| 2026-10-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-06 | SEC |
| 2026-10-06 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-02 | SEC |
| 2026-09-23 | 8-K | Current report | 2026-09-23 | SEC |
| 2026-09-23 | 8-K | Current report | 2026-09-22 | SEC |
| 2026-09-17 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-15 | SEC |
| 2026-09-15 | 8-K | Current report | 2026-09-15 | SEC |
| 2026-09-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-05 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-05 | SEC |
| 2026-09-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-31 | SEC |
| 2026-08-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-14 | SEC |
| 2026-08-11 | 3 | Initial statement of beneficial ownership of securities | 2026-08-07 | SEC |
| 2026-08-11 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-07 | SEC |
| 2026-08-10 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-06 | 8-K | Current report | 2026-08-06 | SEC |
| 2026-07-31 | SCHEDULE 13G | SEC | ||
| 2026-07-13 | 8-K | Current report | 2026-07-13 | SEC |
| 2026-07-01 | 8-K | Current report | 2026-06-25 | SEC |
| 2026-06-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-27 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-10 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-10 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-10 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-10 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-10 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-10 | SEC |
| 2026-06-11 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 13.92% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.26% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.93% |
| STATE STREET CORP | 3.57% |
| DIMENSIONAL FUND ADVISORS LP | 3.31% |
| 325 CAPITAL LLC | 3.25% |
| WELLINGTON MANAGEMENT GROUP LLP | 2.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.45% |
| FMR LLC | 1.99% |
| BANK OF AMERICA CORP /DE/ | 1.72% |
Funds
| Fund | % owned |
|---|---|
| iShares Core S&P Small-Cap ETF | 5.16% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.86% |
| iShares Russell 2000 ETF | 2.39% |
| VANGUARD SMALL-CAP INDEX FUND | 2.06% |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | 1.19% |
| Fidelity Small Cap Index Fund | 1.01% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.98% |
| iShares Russell 2000 Growth ETF | 0.85% |
| DIAMOND HILL SMALL CAP FUND | 0.83% |
| Select Health Care Services Portfolio | 0.81% |
OakChart. ASTH. Cached 15 minutes. Terms